Uncategorized
Omeros reports $75.1 million net loss in 2015
Omeros reported a net loss of $75.1 million, or $2.00 per share, in 2015 compared with $73.7 million, or $2.22 per share, in 2014, according to a company press release. Total costs and expenses were reported at $84.7 million in 2015 compared with $70.5 million in 2014. The additional expenses were primarily attributed to the U.S. commercial launch of Omidria (1% phenylephrine/0.3% ketorolac injection).